Cranberry Tablets Recalled for Potential Mislabeling as Metoprolol Succinate ER
Aidapak Services, LLC is recalling Cranberry Tablets, 450 mg, because they may be mislabeled as Metoprolol Succinate ER, 200 mg.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup. Per the rubric, minor labeling errors and voluntary precautionary recalls are typically scored as Moderate (2).
Plain-English summary
Aidapak Services, LLC is recalling Cranberry Tablets, 450 mg, Over The Counter, NDC 57896084501. The recall is due to a labeling mixup where the product may be mislabeled as Metoprolol Succinate ER, Tablet, 200 mg, NDC 62037083301.
The affected product is identified by the pedigree AD73640_1 and an expiration date of 5/30/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication for the specific NDC and pedigree numbers listed above. If the product matches the description, they should stop using it and contact their pharmacist or the recalling firm for instructions.
The recalled product
- Product
- CRANBERRY Tablet, 450 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 57896084501
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CRANBERRY
- Tablet
- 450 mg has the following code Pedigree: AD73640_1
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Niacin ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Metoprolol Tartrate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Ascorbic Acid Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Propranolol HCL ER Capsules Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cyclobenzaprine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29